1. Home
  2. ADVM vs OCC Comparison

ADVM vs OCC Comparison

Compare ADVM & OCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • OCC
  • Stock Information
  • Founded
  • ADVM 2006
  • OCC 1983
  • Country
  • ADVM United States
  • OCC United States
  • Employees
  • ADVM N/A
  • OCC N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • OCC Telecommunications Equipment
  • Sector
  • ADVM Health Care
  • OCC Industrials
  • Exchange
  • ADVM Nasdaq
  • OCC Nasdaq
  • Market Cap
  • ADVM 94.6M
  • OCC 88.0M
  • IPO Year
  • ADVM 2014
  • OCC 1996
  • Fundamental
  • Price
  • ADVM $4.48
  • OCC $10.10
  • Analyst Decision
  • ADVM Strong Buy
  • OCC
  • Analyst Count
  • ADVM 4
  • OCC 0
  • Target Price
  • ADVM $19.75
  • OCC N/A
  • AVG Volume (30 Days)
  • ADVM 800.9K
  • OCC 102.9K
  • Earning Date
  • ADVM 11-03-2025
  • OCC 09-11-2025
  • Dividend Yield
  • ADVM N/A
  • OCC N/A
  • EPS Growth
  • ADVM N/A
  • OCC N/A
  • EPS
  • ADVM N/A
  • OCC N/A
  • Revenue
  • ADVM $1,000,000.00
  • OCC $72,694,849.00
  • Revenue This Year
  • ADVM $1,449.40
  • OCC N/A
  • Revenue Next Year
  • ADVM N/A
  • OCC N/A
  • P/E Ratio
  • ADVM N/A
  • OCC N/A
  • Revenue Growth
  • ADVM N/A
  • OCC 12.67
  • 52 Week Low
  • ADVM $1.78
  • OCC $2.02
  • 52 Week High
  • ADVM $8.56
  • OCC $11.44
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 53.05
  • OCC 59.47
  • Support Level
  • ADVM $4.11
  • OCC $8.16
  • Resistance Level
  • ADVM $5.59
  • OCC $11.38
  • Average True Range (ATR)
  • ADVM 0.52
  • OCC 1.28
  • MACD
  • ADVM -0.09
  • OCC -0.08
  • Stochastic Oscillator
  • ADVM 27.75
  • OCC 62.57

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About OCC Optical Cable Corporation

Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.

Share on Social Networks: